Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy

被引:59
作者
Noh, Ji-Yoon [1 ]
Yoon, Suk Ran [1 ,2 ]
Kim, Tae-Don [1 ,2 ]
Choi, Inpyo [1 ,2 ]
Jung, Haiyoung [1 ]
机构
[1] Korea Res Inst Biosci & Biotechnol KRIBB, Immunotherapy Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea
[2] Univ Sci & Technol UST, Dept Funct Genom, 113 Gwahak Ro, Daejeon 34113, South Korea
基金
新加坡国家研究基金会;
关键词
HUMAN NK CELLS; DOUBLE-STRANDED-RNA; PLASMACYTOID DENDRITIC CELLS; NF-KAPPA-B; SIGNAL-TRANSDUCTION; CYTOKINE PRODUCTION; CRYSTAL-STRUCTURE; ADAPTER MOLECULE; IMMUNE-RESPONSES; GAMMA SECRETION;
D O I
10.1155/2020/2045860
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Innate immunity represents the first barrier for host defense against microbial infection. Toll-like receptors (TLRs) are the most well-defined PRRs with respect to PAMP recognition and induction of innate immune responses. They recognize pathogen-associated molecular patterns (PAMPs) and trigger innate immune responses by inducing inflammatory cytokines, chemokines, antigen-presenting molecules, and costimulatory molecules. TLRs are expressed either on the cell surface or within endosomes of innate immune cells. NK cells are one of the innate immune cells and also express TLRs to recognize or respond to PAMPs. TLRs in NK cells induce the innate immune responses against bacterial and viral infections via inducing NK cytotoxicity and cytokine production. In this review, we will discuss the expression and cellular function of TLRs in NK cells and also introduce some therapeutic applications of TLR agonists for NK cell-mediated immunotherapy.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Toll-Like Receptors, Their Ligands, and Atherosclerosis
    Hodgkinson, Conrad P.
    Ye, Shu
    [J]. THESCIENTIFICWORLDJOURNAL, 2011, 11 : 437 - 453
  • [42] Toll-like receptors and liver disease
    Kesar, Vivek
    Odin, Joseph A.
    [J]. LIVER INTERNATIONAL, 2014, 34 (02) : 184 - 196
  • [43] Toll-like receptors in immune response to the viral infections
    Mikula, I., Jr.
    Pastorekova, S.
    Mikula, I., Sr.
    [J]. ACTA VIROLOGICA, 2010, 54 (04) : 231 - 245
  • [44] Structure of Toll-Like Receptors, Signal Transduction, and Regulation
    Wang, Jian
    Cao, Wei-Ya
    Cai, Wen-Jie
    Li, Cun-Di
    Sun, Lin
    [J]. NANOSCIENCE AND NANOTECHNOLOGY LETTERS, 2017, 9 (05) : 624 - 639
  • [45] Advances in Antiviral Therapies Targeting Toll-like Receptors
    Shah, Masaud
    Anwar, Muhammad Ayaz
    Kim, Jae-Ho
    Choi, Sangdun
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (04) : 437 - 453
  • [46] Toll-like Receptors from the Perspective of Cancer Treatment
    Javaid, Nasir
    Choi, Sangdun
    [J]. CANCERS, 2020, 12 (02)
  • [47] Toll-Like Receptor 3 Expressing Tumor Parenchyma and Infiltrating Natural Killer Cells in Hepatocellular Carcinoma Patients
    Chew, Valerie
    Tow, Charlene
    Huang, Caleb
    Bard-Chapeau, Emilie
    Copeland, Neal G.
    Jenkins, Nancy A.
    Weber, Achim
    Lim, Kiat Hon
    Toh, Han Chong
    Heikenwalder, Mathias
    Ng, Irene Oi-Lin
    Nardin, Alessandra
    Abastado, Jean-Pierre
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (23): : 1796 - 1807
  • [48] Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma
    Deng, Shuanglin
    Zhu, Shan
    Qiao, Yuan
    Liu, Yong-Jun
    Chen, Wei
    Zhao, Gang
    Chen, Jingtao
    [J]. PROTEIN & CELL, 2014, 5 (12) : 899 - 911
  • [49] Toll-like receptors: The role in bladder cancer development, progression and immunotherapy
    Moghadam, Solmaz Ohadian
    Nowroozi, Mohammad Reza
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2019, 90 (06)
  • [50] Toll-like receptors and cancer
    Rakoff-Nahoum, Seth
    Medzhitov, Ruslan
    [J]. NATURE REVIEWS CANCER, 2009, 9 (01) : 57 - 63